NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the recipient of a significant drop in short interest in April. As of April 15th, there was short interest totalling 400 shares, a drop of 99.4% from the March 31st total of 65,900 shares. Based on an average daily trading volume, of 1,568,900 shares, the short-interest ratio is presently 0.0 days.
NovAccess Global Price Performance
NovAccess Global stock opened at $0.01 on Friday. The firm’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.03. NovAccess Global has a 1-year low of $0.01 and a 1-year high of $0.22.
NovAccess Global (OTCMKTS:XSNX – Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.01 earnings per share for the quarter.
About NovAccess Global
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Further Reading
- Five stocks we like better than NovAccess Global
- Transportation Stocks Investing
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is the Euro STOXX 50 Index?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Which Wall Street Analysts are the Most Accurate?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
